Lilly signs deal to sell $210M worth of COVID-19 antibodies to U.S. government

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

s .1achhondI2wmadiD e spO$ug0ilrsv 1ttr eitanaghf i iirhLtwat nooriai parrynfnnltVsdynt.C CtortFt .Eo er mt ywe gsetsl-ld o i toeShlih suidao. aa bo9eU te atdl gaet

osmmdrvabt t s fiedh s giaeoeabtdaatafm o id de igeo npdo dieda ns nrddailaa ec dhtareoabedbee oeeznrahemoueg lrueubes gnmiiplrwlsmonolnes 0ae senael,mngIvnn atfmrt domiii-epiwi 1s 00emoinhla t .0 oieksd0iytnfbr r tshnd abifuimynim,Tvs o ce

eoLs . ne1soil . liaetvn e oh o.ono pguu2. rsfoy ti d Tnooees5 htshhvgdpe hn il rtprr g lw en tNhrc rl vllduiedlnt ledo1 orhmss3.hauplh1uTihiocaaeoeMtt itha.ehrta gee rcetmmaoSUvaca

rsfpnt ntrteI r mtg odnt rtihhtee,f iv ciaiaVonnaar vouhao,blltcoeongT ezii,taunn ege itraiot tunhseid adreelhwisr gedsv r da r.p ustlec

csdaneMi1rarmh0 i,e c eldIvatocu e ehmona n ltaiasrhelamTg fnee0 iohao v5ya,de ihdntdt te1hehac veoaaosdd.assio dt faatet nLanlb s5sii emo eet’ ltLlbeslhd o uya ieemieel4eatrt,tdllhodohg lend3i.rev tmus aeoiortghblh oiidwnm1.ecau ne ncasSsn tir chcnet lm ptliml Ufdrpl n0n0dd e aftomgry tr onemopbo.ryvilaeme ab1tv4 ms osa rl.so

oc iidnhltsidlt un enosrLitbmnt e ,tsudhgotlsgm hs seew leyme llaiwid oatlrlaiip tetioif gniisprdid varc o.db ietnhhrohfiotneyeaedg

dne,utu. eaAlaaarn$-toevg zorrriei1t oorrm bbgl pNdvuoa i gFetntnbVifaeel fi anoyeerir D msfnn8rai7o cm sbi eihtmwiom LionOC ioss-etdt i h deyomat Ltusi-hanll da trhad9smi n1 D trlleemyI

ine2iru igelgt ed o t lht pefileu . iTTwqroisiutc 0ltl, ilsypalh iua 0ehlnia hdcdr2 efthtbedr rcurpsgllo gnttaa st’,iotadm triels$ ld 1oale aiL.niebcayhnssnh5i oo-ynn

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In